Reducing Opioid Abuse Liability: Insights from a $2.3 Million NIDA Grant

Wednesday, 25 September 2024, 08:57

NIDA Grant awarded to CMSRU for innovative opioid abuse reduction research. Amanda Fakira's pioneering work aims to tackle opioid addiction effectively. The funding will support groundbreaking studies focusing on novel strategies to minimize abuse liability associated with opioids.
Rowan
Reducing Opioid Abuse Liability: Insights from a $2.3 Million NIDA Grant

NIDA Grant Recognition

Cooper Medical School of Rowan University (CMSRU) is excited to announce the remarkable achievement of Amanda Fakira, PhD, an assistant professor in biomedical sciences. She has received a prestigious R01 grant from the National Institute on Drug Abuse (NIDA), totaling $2.3 million, dedicated to researching novel approaches for reducing the abuse liability of opioids.

Innovative Strategies for Opioid Research

This significant funding will empower Dr. Fakira to conduct groundbreaking studies targeted at formulating innovative strategies aimed at addressing opioid addiction. The emphasis will be on exploring new methodologies that can effectively mitigate the risks associated with opioid use and dependency.

  • Focus on preventative measures to combat opioid addiction.
  • Investigation into safer alternatives for pain management.
  • Collaboration with leading experts in addiction science.

As opioid abuse remains a critical public health issue, the efforts spearheaded by Dr. Fakira through this esteemed grant represent a profound commitment to improving health outcomes for individuals at risk of addiction.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe